Pacira Pharmaceuticals buy Wedbush
Start price
08.02.24
/
50%
€25.80
Target price
08.02.25
€53.03
Performance (%)
-0.78%
End price
09.02.25
€25.60
Summary
This prediction ended on 09.02.25 with a price of €25.60. During the runtime of the prediction for Pacira Pharmaceuticals the price only changed by -0.78%. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -2.475% | -2.475% | -6.190% |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% |
Comments by Wedbush for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Wedbush gewählte maximale Laufzeit wurde überschritten